Market Research Logo

Horizon Pharma Plc (HZNP) - Financial and Strategic SWOT Analysis Review

Horizon Pharma Plc (HZNP) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Horizon Pharma plc (Horizon Pharma) is a pharmaceutical company which develops and commercializes medical products for the treatment of pain, arthritis and inflammatory diseases. It markets medicines through its orphan, primary care and rheumatology business units. The company’s marketed products include Actimmune, Buphenyl, Duexis, Krystexxa, Migergot, Pennsaid 2%, Procysbi, Quinsair, Ravicti, Rayos and Vimovo. Horizon Pharma provides products and services to patients and healthcare professionals in the US. The company operates through offices in Illinois, California, Switzerland, the Netherlands and Germany. Horizon Pharma is headquartered in Dublin, Ireland.

Horizon Pharma Plc Key Recent Developments

Jun 04,2018: Horizon Pharma and the National Organization for Rare Disorders (NORD) Illustrate 35 years of Progress in Rare Disease at the Biotechnology Innovation Organization (BIO) International Convention
May 22,2018: Horizon Pharma Named One of the Best Small and Medium Workplaces in Chicago by FORTUNE
May 09,2018: Horizon Pharma Reports Strong First-Quarter 2018 Orphan and Rheumatology Net Sales Growth
Feb 28,2018: Horizon Pharma Announces Fourth-Quarter and Full-Year 2017 Results
Jan 08,2018: Horizon Pharma Increases Peak Net Sales Guidance for Key Growth Drivers and Announces Rheumatology and Orphan Pipeline Developments

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Horizon Pharma Plc - Key Facts
Horizon Pharma Plc - Key Employees
Horizon Pharma Plc - Key Employee Biographies
Horizon Pharma Plc - Major Products and Services
Horizon Pharma Plc - History
Horizon Pharma Plc - Company Statement
Horizon Pharma Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Horizon Pharma Plc - Business Description
Horizon Pharma Plc - SWOT Analysis
SWOT Analysis - Overview
Horizon Pharma Plc - Strengths
Horizon Pharma Plc - Weaknesses
Horizon Pharma Plc - Opportunities
Horizon Pharma Plc - Threats
Horizon Pharma Plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Horizon Pharma Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jun 04, 2018: Horizon Pharma and the National Organization for Rare Disorders (NORD) Illustrate 35 years of Progress in Rare Disease at the Biotechnology Innovation Organization (BIO) International Convention
May 22, 2018: Horizon Pharma Named One of the Best Small and Medium Workplaces in Chicago by FORTUNE
May 09, 2018: Horizon Pharma Reports Strong First-Quarter 2018 Orphan and Rheumatology Net Sales Growth
Feb 28, 2018: Horizon Pharma Announces Fourth-Quarter and Full-Year 2017 Results
Jan 08, 2018: Horizon Pharma Increases Peak Net Sales Guidance for Key Growth Drivers and Announces Rheumatology and Orphan Pipeline Developments
Nov 30, 2017: Horizon Pharma Names Shao-Lee Lin, M.D., Ph.D. Executive Vice President, Research and Development and Chief Scientific Officer
Nov 06, 2017: Horizon Pharma Announces Third-Quarter and Year-to-Date 2017 Results
Oct 26, 2017: Horizon Pharma to Leverage Medidata Clinical Cloud and eTMF Solutions to Support its Business Transformation
Oct 26, 2017: Horizon Pharma plc to Leverage Medidata Clinical Cloud and eTMF Solutions to Support its Business Transformation
Oct 17, 2017: Horizon Pharma Named One of the Best Small & Medium Workplaces by FORTUNE and Great Place to Work for the Second Year in a Row
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Horizon Pharma Plc, Key Facts
Horizon Pharma Plc, Key Employees
Horizon Pharma Plc, Key Employee Biographies
Horizon Pharma Plc, Major Products and Services
Horizon Pharma Plc, History
Horizon Pharma Plc, Subsidiaries
Horizon Pharma Plc, Key Competitors
Horizon Pharma Plc, Ratios based on current share price
Horizon Pharma Plc, Annual Ratios
Horizon Pharma Plc, Annual Ratios (Cont...1)
Horizon Pharma Plc, Annual Ratios (Cont...2)
Horizon Pharma Plc, Interim Ratios
Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Horizon Pharma Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Horizon Pharma Plc, Performance Chart (2013 - 2017)
Horizon Pharma Plc, Ratio Charts
Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report